Stay updated on INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial page.

Latest updates to the INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial page
- Check6 days agoChange Detected- The page now shows revision: v3.4.3, replacing the previous revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed notices about government funding lapses and the previous Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding lapse notice across the site. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a UI Show glossary option and updated the footer to include No FEAR Act Data and Revision: v3.4.0 (replacing Revision: v3.3.4). Capitalization changes to No FEAR Act text are included, but the core study content remains unchanged.SummaryDifference0.2%

- Check62 days agoChange DetectedFooter revision text updated from v3.3.3 to v3.3.4, indicating a minor platform update.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter updates include the addition of 'Revision: v3.3.3' and removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2', which do not affect study details or how to use the trial page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial page.